Ravi Rangara

1.6k total citations · 1 hit paper
7 papers, 1.4k citations indexed

About

Ravi Rangara is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Ravi Rangara has authored 7 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Biotechnology. Recurrent topics in Ravi Rangara's work include RNA Interference and Gene Delivery (5 papers), Virus-based gene therapy research (5 papers) and CRISPR and Genetic Engineering (3 papers). Ravi Rangara is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Virus-based gene therapy research (5 papers) and CRISPR and Genetic Engineering (3 papers). Ravi Rangara collaborates with scholars based in France and Morocco. Ravi Rangara's co-authors include Daniel Scherman, Bertrand Schwartz, Michel F. Bureau, Lluis M. Mir, P. Delaère, Julie Gehl, Didier Rouy, Jean‐Michel Caillaud, Didier Branellec and Brian Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Gene Therapy.

In The Last Decade

Ravi Rangara

7 papers receiving 1.3k citations

Hit Papers

High-efficiency gene transfer into skeletal muscle mediat... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Rangara France 7 892 601 431 326 217 7 1.4k
Bertrand Schwartz France 11 983 1.1× 590 1.0× 409 0.9× 322 1.0× 221 1.0× 16 1.6k
E. Neumann Germany 11 999 1.1× 1.7k 2.8× 214 0.5× 1.2k 3.8× 278 1.3× 12 2.4k
Masayuki Fukumura Japan 14 457 0.5× 142 0.2× 357 0.8× 151 0.5× 91 0.4× 27 958
Stella Somiari United States 9 304 0.3× 248 0.4× 123 0.3× 109 0.3× 105 0.5× 12 589
Deyao Zhao China 21 691 0.8× 226 0.4× 84 0.2× 397 1.2× 111 0.5× 42 1.1k
Franck M. André France 22 686 0.8× 1.6k 2.7× 158 0.4× 1.2k 3.8× 386 1.8× 47 2.3k
Carole Bloquel France 14 392 0.4× 146 0.2× 171 0.4× 109 0.3× 122 0.6× 15 802
Ken‐ichi Yano Japan 16 911 1.0× 191 0.3× 127 0.3× 122 0.4× 96 0.4× 24 1.2k
Urška Kamenšek Slovenia 17 370 0.4× 557 0.9× 118 0.3× 252 0.8× 243 1.1× 52 841
Claudia Muratori United States 15 280 0.3× 253 0.4× 35 0.1× 136 0.4× 231 1.1× 28 746

Countries citing papers authored by Ravi Rangara

Since Specialization
Citations

This map shows the geographic impact of Ravi Rangara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Rangara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Rangara more than expected).

Fields of papers citing papers by Ravi Rangara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Rangara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Rangara. The network helps show where Ravi Rangara may publish in the future.

Co-authorship network of co-authors of Ravi Rangara

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Rangara. A scholar is included among the top collaborators of Ravi Rangara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Rangara. Ravi Rangara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Schwartz, Brian, Bruno Pitard, Virginie Escriou, et al.. (1999). Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Therapy. 6(2). 282–292. 78 indexed citations
2.
Rangara, Ravi, P Kreiss, Brian Schwartz, et al.. (1999). Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Therapy. 6(2). 209–218. 128 indexed citations
3.
Mir, Lluis M., Michel F. Bureau, Julie Gehl, et al.. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proceedings of the National Academy of Sciences. 96(8). 4262–4267. 749 indexed citations breakdown →
4.
Mir, Lluis M., Michel F. Bureau, Ravi Rangara, Bertrand Schwartz, & Daniel Scherman. (1998). Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 321(11). 893–899. 147 indexed citations
5.
Byk, Gérardo, Catherine Dubertret, Virginie Escriou, et al.. (1998). Synthesis, Activity, and Structure−Activity Relationship Studies of Novel Cationic Lipids for DNA Transfer. Journal of Medicinal Chemistry. 41(2). 224–235. 198 indexed citations
6.
Byk, Gérardo, Catherine Dubertret, Bertrand Schwartz, et al.. (1997). Novel nonviral vectors for gene delivery: Synthesis and applications. Letters in Peptide Science. 4(4-6). 263–267. 6 indexed citations
7.
Schwartz, Brian, et al.. (1996). Gene transfer by naked DNA into adult mouse brain.. PubMed. 3(5). 405–11. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026